AIMS Facilitates Investor Exit for OrbiMed, BII via Private Credit

BANKINGFINANCE
Whalesbook Logo
AuthorIshaan Verma|Published at:
AIMS Facilitates Investor Exit for OrbiMed, BII via Private Credit

Asian Institute of Medical Sciences has enabled a full exit for private equity investors, OrbiMed and British International Investment, through a structured financial arrangement. The deal involves new private credit funding from 360 ONE and debt refinancing from Hero FinCorp, allowing the promoter group to consolidate ownership. This move highlights how private healthcare firms are managing investor liquidity and ownership transitions without an immediate public market listing.

What Happened

Asian Institute of Medical Sciences (AIMS), a multi-specialty hospital chain based in Faridabad, has successfully facilitated an exit for its longstanding private equity investors, OrbiMed Asia II Mauritius Limited and British International Investment (formerly CDC Group). The deal allows the promoter group, led by founder Dr. N. K. Pandey, to acquire the shares previously held by these private equity backers. The entire transaction, including the acquisition of shares and restructuring of existing debt, was advised by DSK Legal.

The Financial Mechanics

The exit was achieved through a structured financial strategy designed to provide liquidity to the outgoing investors. The company secured a fresh private credit facility from 360 ONE, which provided the necessary capital for the buyback. Simultaneously, AIMS worked with Hero FinCorp to refinance its existing loan facility, which was previously held with HDFC Bank. By consolidating these debt arrangements, the hospital chain was able to fund the payout to the private equity firms while managing its ongoing debt obligations.

Why This Matters for Private Healthcare

For investors observing the Indian healthcare space, this transaction provides insight into how private hospital chains handle investor lifecycle transitions. Unlike large, publicly traded hospital chains that may offer an exit to private equity investors through an Initial Public Offering (IPO) or a strategic sale, private companies often rely on internal buybacks. This transaction suggests that the promoters are aiming to consolidate control over the business. It also demonstrates the growing role of private credit in India, where non-banking financial companies (NBFCs) and credit funds are increasingly stepping in to provide capital for such corporate events.

The Role of Private Credit and Refinancing

The use of private credit from 360 ONE and refinancing from Hero FinCorp indicates that the company is comfortable utilizing debt to manage its capital structure. For any hospital chain, maintaining a balance between expansion—often requiring heavy capital investment in medical equipment and infrastructure—and debt repayment is crucial. Investors often look for signs that such debt levels remain manageable and that cash flows from hospital operations are sufficient to service these new repayment obligations.

What to Watch Next

As the company moves forward with consolidated promoter ownership, the key areas for observers will be the operational performance of its hospital network and its capital allocation strategy. Investors should track the company’s ability to manage its debt-to-equity ratio following this refinancing. Additionally, any future updates regarding potential strategic growth or further expansion plans into tier-II and tier-III cities—a stated focus area for the hospital chain historically—will indicate how effectively the management is deploying capital after the ownership transition.

Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.